Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

20.75
Delayed Data
As of 4:00pm ET
 +0.24 / +1.17%
Today’s Change
11.60
Today|||52-Week Range
24.57
+7.57%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close20.51
Today’s open20.36
Day’s range20.25 - 20.75
Volume266,911
Average volume (3 months)657,473
Market cap$773.9M
Dividend yield--
Data as of 4:00pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-137.92%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+254.19%
P/E ratioNM
Price/Sales7.26
Price/Book2.49

Competitors

 Today’s
change
Today’s
% change
CRSPCRISPR Therapeutics ...+0.21+1.01%
BPMCBlueprint Medicines ...+1.46+5.57%
ANIPANI Pharmaceuticals ...-1.41-2.39%
MYOVMyovant Sciences Ltd+0.11+1.04%
Data as of 4:00pm ET, 12/08/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$99.9M
Annual profit (last year)$117.2M
Net profit margin117.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil McFarlane
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs